Esco西林瓶灌装加塞（轧盖）机

Overview

The Esco VFS-CR Series Vial Filling, Stoppering & Crimping Machine is an aseptic processing platform engineered for research, development, and pilot-scale manufacturing of sterile biopharmaceuticals. Designed in accordance with core principles of isolator-based aseptic processing and Good Manufacturing Practice (GMP) Annex 1 (2022), the system integrates volumetric filling, vacuum-assisted stopper placement, and crimping into a single compact footprint. It operates on a closed-system architecture with configurable isolator integration—enabling containment of potent compounds including monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), viral vectors, plasmid DNA, and cell therapy products. The machine supports both liquid and lyophilized formulations across vial sizes ranging from 2 mL to 100 mL, including Ready-to-Use (RTU) pre-sterilized glass or polymer vials. Its maximum throughput is 3,000 vials per hour under validated operating conditions, with cycle time scalability optimized for process characterization studies and tech-transfer readiness.

Key Features

• Full servo-driven motion control architecture ensures repeatable positioning accuracy (< ±0.15 mm) and synchronized actuation across filling, stoppering, and crimping stations.
• Modular pump selection: precision piston pumps (for high-viscosity, low-shear applications) or peristaltic pumps (for shear-sensitive biologics), supporting fill volumes from 0.5 mL to 100 mL with linearity ≤ ±1.0% RSD at nominal setpoint.
• Integrated In-Process Control (IPC) via load-cell-based gravimetric weighing—100% vial-by-vial weight verification with real-time deviation flagging and auto-rejection capability.
• Pick-and-place stopper handling using vacuum suction cups with programmable dwell time and pressure control to prevent stopper deformation or particulate generation.
• Pneumatic crimping heads designed to eliminate aluminum particulates; compliant with ISO 8573-1 Class 2 compressed air quality requirements and validated for consistent torque application (±5% variation).
• On-line sampling port and automatic defective vial ejection—fully traceable via event logging and timestamped audit trail.
• Optional nitrogen purge module with three configurable injection points: pre-fill, during fill, and post-fill/pre-stopper—enabling oxygen reduction < 0.5% v/v for oxidation-sensitive therapeutics.

Sample Compatibility & Compliance

The VFS-CR series accommodates standard USP/Ph. Eur.-compliant 2–100 mL serum vials (Type I borosilicate glass, polymer-coated variants, or cyclic olefin copolymer vials). It accepts standard rubber stoppers (bromobutyl, chlorobutyl, fluorocarbon-coated) and aluminum crimp seals meeting ISO 8362-1 specifications. All wetted parts are constructed from electropolished 316L stainless steel (Ra ≤ 0.4 µm) and FDA-compliant elastomers. The system supports qualification protocols aligned with ASTM E2500, ISO 13485, and EU GMP Annex 1. When integrated with an Esco isolator (e.g., Axiom™ or LabGard™ ISO 5 systems), it meets ISO 14644-1 Class 5 environmental control requirements. The design supports 21 CFR Part 11-compliant electronic records and signatures when paired with Esco’s validated SCADA interface.

Software & Data Management

Controlled by Esco’s proprietary HMI/SCADA platform running on Windows IoT Enterprise, the system provides full recipe management, parameter locking, user-level access control (admin/operator/maintainer tiers), and electronic batch record (EBR) export in PDF/A-2 format. All critical process parameters—including fill weight, crimp torque, nitrogen flow rate, vacuum level, and stopper placement force—are logged at ≥1 Hz resolution with embedded checksum integrity validation. Audit trails are immutable, time-stamped, and include operator ID, action type, and pre-/post-value changes—fully compliant with ALCOA+ data integrity principles. Optional integration with MES/LIMS via OPC UA 1.04 is available for enterprise-level data aggregation.

Applications

This platform is routinely deployed in biopharma R&D labs, CMC departments, and contract development and manufacturing organizations (CDMOs) for: formulation stability studies requiring low-volume fill accuracy; clinical trial material (CTM) production (Phase I–II); process validation support (IQ/OQ/PQ); lyophilization cycle development using pre-filled vials; and comparability studies following manufacturing site transfers. It serves as a scalable bridge between lab-scale peristaltic fillers and commercial rotary fillers—reducing risk in early-phase tech transfer while maintaining regulatory-aligned documentation standards.

FAQ

Is this machine suitable for GMP manufacturing?

Yes—when installed in a qualified cleanroom or isolator environment and operated under approved SOPs, the VFS-CR series supports GMP-compliant production up to commercial Phase III and commercial launch batches.

Can it handle freeze-dried products?

Yes—the system supports both liquid fills and post-fill lyophilization-ready configurations, including stopper half-stop position control and nitrogen backfill prior to freeze-drying.

What validation support does Esco provide?

Esco delivers comprehensive DQ/IQ/OQ documentation packages, FAT/SAT protocols, and URS alignment support—available under NDA-restricted access upon project engagement.

Is remote monitoring supported?

Yes—via optional secure VPN-enabled remote diagnostics and real-time KPI dashboards accessible through Esco’s cloud-connected service portal.

Does it comply with FDA 21 CFR Part 11?

Yes—when configured with Esco’s validated software package, including electronic signature workflows, audit trail encryption, and role-based access controls.